Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. Mai 2016 08:05 ET | Quelle: Nemucore Medical Innovations, Inc.

Nemucore Study Published in Molecular Pharmaceutics Furthers Understanding of NMI-350 and Theranostics for Ovarian Cancer

WORCESTER, Mass., May 23, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a clinical-stage biopharmaceutical company dedicated to the development of therapies targeting highly...
16. Mai 2016 08:05 ET | Quelle: Nemucore Medical Innovations, Inc.

Nemucore Medical Innovations Announces Appointment of Nicholas De Monico to its Board of Directors

WORCESTER, Mass., May 16, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies targeting...
12. Mai 2016 08:05 ET | Quelle: Nemucore Medical Innovations, Inc.

Nemucore Medical Innovations Announces NMI-350 ACOG Poster Presentation

WORCESTER, Mass., May 12, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
11. Mai 2016 08:05 ET | Quelle: Nemucore Medical Innovations, Inc.

Nemucore Medical Innovations Announces NMI-500 ACOG Poster Presentation

WORCESTER, Mass., May 11, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
05. April 2016 08:05 ET | Quelle: Nemucore Medical Innovations, Inc.

Nemucore Medical Innovations to Present at Needham & Company’s 15th Annual Healthcare Conference

WORCESTER, Mass., April 05, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
14. Dezember 2015 08:05 ET | Quelle: Nemucore Medical Innovations, Inc.

Nemucore Medical Innovations Announces Licensing Agreement With Pfenex Inc. Enabling Manufacture of Anti-Cancer Therapeutic NMI-8000, the Biologically Active Form of Mullerian Inhibitory Substance (MIS)

WORCESTER, Mass., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
09. Dezember 2015 08:05 ET | Quelle: Nemucore Medical Innovations, Inc.

Nemucore Medical Innovations Announces Appointment of Dr. Michael V. Seiden to Its Board of Directors and Clinical Advisory Board

WORCESTER, Mass., Dec. 09, 2015 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
07. Dezember 2015 08:10 ET | Quelle: Nemucore Medical Innovations, Inc.

Nemucore Medical Innovations Options Clinical-Stage Aurora Kinase Inhibitor GSK1070916 From Cancer Research Technology (CRT)

WORCESTER, Mass., Dec. 07, 2015 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
07. Dezember 2015 08:05 ET | Quelle: Nemucore Medical Innovations, Inc.

Nemucore Medical Innovations Completes Series A Financing

WORCESTER, Mass., Dec. 07, 2015 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...